In our study, we validated that miR-486-5p targeted NEK2 to regulate LUAD progression, and simultaneous overexpression of miR-486-5p and NEK2 could rescue the inhibitory effect of miR-486-5p on cancer cell activities. Here, NEK2 is linked to cancer.